About AbbVie

AbbVie discovers and delivers innovative medicines for complex health challenges. With a portfolio spanning immunology, oncology, neuroscience and aesthetics, the company treats over 75 conditions, serving around 60 million people annually across 175+ countries. Their work combines rigorous science with deep patient understanding, partnering with physicians, caregivers and communities to create meaningful solutions. Founded in 2013, AbbVie maintains a robust research pipeline whilst supporting patients beyond the medicine. From Parkinson's disease research to aesthetic medicine, their approach balances focused innovation with commercial scale, ensuring breakthroughs reach those who need them most.